HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Taguchi Selected Research

Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)

1/2017Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.
3/2015Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Taguchi Research Topics

Disease

34Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 02/2005
28Neoplasms (Cancer)
09/2018 - 03/2004
4Neoplasm Metastasis (Metastasis)
01/2018 - 02/2009
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 05/2006
3Sarcoma (Soft Tissue Sarcoma)
04/2016 - 06/2013
2Endocarditis
02/2016 - 06/2010
2Disease Progression
12/2013 - 03/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2018
1Necrosis
01/2018
1Genetic Translocation (Chromosomal Translocation)
01/2017
1Rare Diseases (Rare Disease)
10/2016
1Hepatocellular Carcinoma (Hepatoma)
04/2016
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2016
1Mitral Valve Insufficiency (Mitral Regurgitation)
02/2016
1Leukemia
01/2015
1Contact Dermatitis (Eczema, Contact)
09/2014
1Hypothyroidism
04/2014
1Inflammation (Inflammations)
03/2014
1Eosinophilia
03/2014
1Hypersensitivity (Allergy)
03/2014
1Atopic Dermatitis (Atopic Eczema)
03/2014
1Colonic Polyps
12/2013
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2013
1Renal Cell Carcinoma (Grawitz Tumor)
09/2013
1Glioma (Gliomas)
01/2013
1Type 2 Diabetes Mellitus (MODY)
03/2012
1Kidney Neoplasms (Kidney Cancer)
12/2011

Drug/Important Bio-Agent (IBA)

25Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 02/2005
9Tyrosine Kinase InhibitorsIBA
01/2018 - 09/2009
7Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2015 - 05/2006
6Phosphotransferases (Kinase)IBA
01/2017 - 05/2006
5Pharmaceutical PreparationsIBA
02/2014 - 05/2006
4Biological ProductsIBA
01/2018 - 06/2002
4Proteins (Proteins, Gene)FDA Link
04/2016 - 07/2005
4Biomarkers (Surrogate Marker)IBA
04/2016 - 03/2012
4Sunitinib (Sutent)FDA Link
04/2014 - 09/2006
2InterferonsIBA
02/2017 - 01/2013
2LipopolysaccharidesIBA
02/2017 - 01/2013
2Toll-Like Receptor 4IBA
02/2017 - 01/2013
2Interleukin-17 (Interleukin 17)IBA
02/2017 - 01/2013
2InterleukinsIBA
02/2017 - 01/2013
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 03/2015
2Peptides (Polypeptides)IBA
10/2016 - 08/2015
2Histone Deacetylase InhibitorsIBA
04/2016 - 09/2009
2MicroRNAs (MicroRNA)IBA
01/2015 - 03/2012
2Messenger RNA (mRNA)IBA
01/2015 - 01/2013
2EnzymesIBA
04/2014 - 08/2011
2Sorafenib (BAY 43-9006)FDA Link
09/2013 - 08/2012
1Singlet OxygenIBA
01/2018
1Interleukin-23 (Interleukin 23)IBA
02/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2017
1CytokinesIBA
02/2017
1Immunologic Factors (Immunomodulators)IBA
02/2017
1BombesinIBA
10/2016
1minigastrinIBA
10/2016
1Bombesin Receptors (Bombesin Receptor)IBA
10/2016
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2016
1Histone Deacetylases (Histone Deacetylase)IBA
04/2016
15-ethynyl-2'-deoxyuridineIBA
08/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2015
1binimetinibIBA
03/2015
1Polytetrafluoroethylene (Teflon)FDA Link
09/2014
1Iodide Peroxidase (Deiodinase)IBA
04/2014
1Thyroid HormonesIBA
04/2014
1chlorinIBA
04/2014
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2014
1Glucose (Dextrose)FDA LinkGeneric
04/2014
1Photosensitizing Agents (Photosensitizers)IBA
04/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2014
1fucoxanthinIBA
03/2014
1peridininIBA
03/2014
1Carotenoids (Carotene)IBA
03/2014
1Peptidoglycan (Murein)IBA
12/2013
1Focal Adhesion Protein-Tyrosine KinasesIBA
12/2013
1CalciumIBA
06/2013
1Insulin-Like Growth Factor Binding Protein 5IBA
06/2013
1Chloride Channels (Chloride Channel)IBA
06/2013
1AntibodiesIBA
01/2013
1Glycogen Synthase (Synthase I)IBA
01/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2013
1Polysaccharides (Glycans)IBA
01/2013
1asialo GM1 gangliosideIBA
01/2013
1Muramidase (Lysozyme)IBA
01/2013
1Leptin ReceptorsIBA
03/2012
1Long Noncoding RNAIBA
03/2012
1Oncogene Proteins (Oncogene Protein)IBA
08/2011
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
08/2011
1SurvivinIBA
12/2010

Therapy/Procedure

11Therapeutics
09/2018 - 03/2004
3Nephrectomy
01/2015 - 03/2004
2Precision Medicine
01/2018 - 03/2012
2Immunotherapy
02/2017 - 08/2011
1Molecular Targeted Therapy
09/2018
1Lasers (Laser)
01/2018
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2016
1Thoracotomy
02/2016
1Drug Therapy (Chemotherapy)
04/2014
1Photochemotherapy (Photodynamic Therapy)
04/2014
1Intravenous Administration
04/2014
1Transplantation
01/2013